Pharmacodynamic studies of Chinese medicine at levels of whole animal, cell and molecular models

Current Medicinal Chemistry

Volumn 17, Issue 36, 2010, Pages 4521-4537

  Qv, Xiao Ying ^a   Jiang, Jian Guo ^a   Piao, Jin Hua ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Animal model; Cell membrane chromatography (CMC); Gene chips; Molecular biochromatography (MBC); Molecular model; Pharmacodynamic action; Proteomics; Traditional Chinese medicine (TCM)

Indexed keywords

ANGELICA ROOT; ANGELICA ROOT EXTRACT; ASTRAGALIN; ATRACTYLODES EXTRACT; BERBERINE; BU YANG HUAN WU DECOCTION; CHAIHU DECOCTION; CUSCUTA EXTRACT; DANGGUI BUXUE DECOCTION; FU ZHENG KANG AI FANG; GINKGO BILOBA EXTRACT; GUIZHI SHAOYAO ZHIMU DECOCTION; HERBA EPLMEDII; JINSIWEI; LIBANOTIS BUETHORIMENSIS; LIGUSTICUM CHUANXIONG EXTRACT; LIGUSTRUM LUCIDUM EXTRACT; PAEONIFLORIN; PEACH SEED PROTEIN A; PILOSE ANTLER EXTRACT; PLANT EXTRACT; POLYGONUM CUSPIDATUM EXTRACT; PUERARIN; SALVIA MILTIORRHIZA EXTRACT; SHENSONGY ANGXIN CAPSULE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WUSAN GRANULE; XIAOTAN SANJIE RECIPE; XUEZHIKANG; ZHIXINKANG;

ARTICLE; BIOCHIP; CHINESE MEDICINE; CISTANCHE; DRUG EFFECT; DRUG MEGADOSE; DRUG TARGETING; GENE ACTIVITY; GENE INACTIVATION; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; MEMBRANE BIOLOGY; MOLECULAR MODEL; NONHUMAN; PEACH; POLYGONUM CUSPIDATUM; PROTEOMICS; SALVIA MILTIORRHIZA; SELAGINELLA; TRANSGENIC ANIMAL; TRANSGENICS; WHOLE CELL;

ANIMALS; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; MEDICINE, CHINESE TRADITIONAL; MODELS, BIOLOGICAL; MODELS, MOLECULAR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 78650661879     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710794182926     Document Type: Article

References (94)

1. Cheng, J. T. Review: Drug therapy in Chinese traditional medicine. J. Clin. Pharmacol, 2000, 40, 445-450.
2. Zhang, Z. Q.; Zhang, Y. N.; Tian, Z. J. Screening models and techniques for medicine and its application in the studies on the active components of Chinese medicine. China J. Chin. Mater. Med., 2003, 28, 907-910.
3. Li, F. R.; Wu, Z.; Yang, J. X. The application of modern biotechnology in active component screening of traditional Chinese medicine. China J. Chin. Mater. Med., 2004, 29, 1099-1101.
4. Zhao, X. L.; Zhang, X. Z.; Di, L. Q.; Wang, S. C.; Cai, B. C.; Du, Q.; Shan, J. J.; Bi, X. L.; Wei, H. M. Exploration of thoughts and methods in study on material base of traditional chinese medicinal herbs prescriptions. Mode. Trad. Chin. Med. Mater. Med., 2009, 11, 488-492.
5. Mroczek, T.; Ndjoko, K.; Glowniak, K.; Hostettmann, K. On-line structure characterization of pyrrolizidine alkaloids in Onosma stellulatum and Emilia coccinea by liquid chromatography-ion-trap mass spectrometry. J. Chromatogr. A, 2004, 1056, 91-97.
6. Dhooghe, L.; Mesia, K.; Kohtala, E.; Tona, L.; Pieters, L.; Vlietinck, A. J.; Apers, S. Development and validation of an HPLC-method for the determination of alkaloids in the stem bark extract of Nauclea pobeguinii. Talanta, 2008, 76, 462-468.
7. Kitano H. Systems biology: a brief overview. Science, 2002, 295, 1662-1664.
8. Li, P.; Yang, L. P.; Gong, Y. W. Application of systems biology technology in research of traditional chinese medicine. J. Tradit. Chin. Med., 2009, 29, 153-157.
9. Wang, M.; Lamers, R. J. A. N.; Korthout, H. A. A. J.; Joop H. J. van Nesselrooij, J. H. J.; Witkamp, R. F.; Heijden, R. van der; Voshol, P. J.; Havekes, L. M.; Verpoorte, R.; Greef, J. van der. Metabolomics in the context of systems biology: bridging traditional chinese medicine and molecular pharmacology. Phytother. Res., 2005, 19, 173-182.
10. Roses, A. D. Genome-based pharmacogenetics and the pharmaceutical industry. Nat. Rev. Drug Discov., 2002, 1, 541-549.
11. McCarthy, J. J. Advances in pharmacogenomic research and development. Mol. Biotechnol, 2003, 25, 275-282.
12. Houdebine, L. M. The methods to generate transgenic animals and to control transgene expression. J. Biotechnol, 2002, 98, 145-160.
13. Bunz, F. Human cell knockouts. Curr. Opin. Oncol, 2002, 14, 73-78.
14. Rago, C; Vogelstein, B.; Bunz, F. Genetic knockouts and knockins in human somatic cells. Nat. Protocols, 2007, 2, 2734-2746.
15. Vidalin, O.; Muslmani, M.; Clément Estienne, C; Echchakir, H.; Abina, A. M. In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine. Curr. Opin. Pharmacol, 2009, 9, 669-676.
16. Goffinet, C; Allespach, I.; Keppler, O. T HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proc. Natl. Acad. Sci. USA, 2007, 104, 1015-1020.
17. Zhang, W. G.; Zheng, G. J. Effect of Zhixinkang capsule on Atherosclerosis (AS) formation in apolipoprotein E-gene knockout mice. J. Biomed. Eng. Res., 2003, 22, 55-58.
18. Zheng, G. J.; Zhang, W. G.; Zhang, Y. T.; Zhang, Y. F.; Ma, X. S. Xue Zhi Kang's effect in preventing the Arteriosclerosis of Apolipoprotein E deficient mice. Chin. J. Arter, 2003, 11, 408-410.
19. Zhang, Q.; Wu, H.; Jiang, Y., Liu, W.; Zeng, S. P.; Feng, Q. S.; Xu, J. H.; Zhao, Z. Y. Effects of guizhi shaoyao zhimu decoction on CRP and IL-2 level in collagen induced arthritis of transgenic mice. J. Tradit. Chin. Med., 2005, 16, 854-856.
20. Hu, Y; Zhang, J. M.; Wang, H.; He, W. Efficacy of Chinese herbs on improving the behavioral ability of PDAPP transgenic mice. Chin. J. Neuroimmunol. Neurol, 2004, 11, 17-24.
21. Zhang, L. M. Tian, J. Z.; Yin, J. X.; Shi, J.; Wang, P. W.; Wang, R. Hu, Q.; Ren, Y. Protection of compound JSW prescription on nerve injury in hippocampal area of APPV717ltransgenic mice. Chin. Tradit. Herbal Drugs, 2009, 40, 410-415.
22. Han, Y. S.; Zhou, Z. G. The effects and immunologic mechanism of Bu Yang Huan Wu decoction for p-amyloid protein of AD rats caused by Ap1-40. Lishizhen Med. Meter. Med. Res., 2009, 20, 9-11.
23. Peng, L. J.; Lu, D. X.; Qi, R. B.; Zhang, T; Sun, Y; Wang, Z. Effect of Fu Zheng Kang Ai Fang a Chinese medicine, on implanted hepatoma in rats. Chin. J. Pathophysiol, 2009, 25, 682-687.
24. Liu, Y; Li, Y. J.; Zhu, L. Y Effect of peach seed protein A on gene expression in mouse with S180. Chin. Trad. Pat. Med., 2004, 26, 398-401.
25. Guo, X. D.; Wei, PK. Effect of Xiaotan Sanjie Recipe on growth of transplanted tumor and expressions of proliferating cell nuclear antigen and epidermal growth factor receptor in tissue of gastric carcinoma of nude mice. J. Integr. Med., 2007, 5, 432-436.
26. Shi, X. P; Zang, Z. H.; Xin, Z. W.; Zhou, Y; Gao, L. Y; Shen, Y. J.; Huang, X. F. Analysis of anti-Lewis lung carcinoma related targetgene in tumor tissue treated by Wusan Granule by cDNA microarray. Chin. J. Integr. Trad. West. Med., 2003, 23, 530-532.
27. Johnston, PA. Cellular platforms for HTS: three case studies. Drug Disc. Today, 2002, 7, 353-363.
28. Horrocks, C; Halse, R.; Suzuki, R.; Shepherd, PR. Human cell systems for drug discovery. Curr. Opin. Drug Disc. Devel, 2003, 6, 570-575.
29. Sundberg, S. A. High-throughput and ultra-high-throughput screening: solution and cell-based approaches. Curr. Opin. Biotechnol, 2000, 11, 47-53.
30. Slater, K. Cytotoxicity tests for high-throughput drug discovery. Curr. Opin. Biotechnol, 2001, 12, 70-74.
31. Li, S. L.; Ping Li, P.; Sheng, L. H.; Li, R. Y; Qi, L. W.; Zhang, L. Y. Live cell extraction and HPLC-MS analysis for predicting bioactive components of traditional Chinese medicines. J. Pharm. Biomed. Anal, 2006, 41, 576-581.
32. Shi, Y. Y.; Zhan, H. S.; Zhao, Y. F.; Shen, P. Z.; Xu, Y Cytologic study on prevention and treatment of primary osteoporosis with Chinese drugs for tonifying the kidney. J. Trad. Chin. Med., 2001, 42, 621-623.
33. Chen, X. C.; Ke, L. J.; Chen, G. R.; Liu, S. T.; Huo, Y. S.; Rao, PF. The modulation of pilose antler extract (PAE) on the proliferation of rat osteogenic cells UMR-106. China J. Chin. Mater. Med., 2004, 29, 74-77.
34. Zhao, P. W.; Wang, D. W.; Niu, J. Z.; Wang, J. F.; Wang, Q. L. Evaluation on phytoestrogen effects of ten kinds of Chinese medicine including flos carthami. China J. Chin. Mater. Med., 2007, 32, 436-439.
35. Feng, L.; Zhang, L. F.; Yan, T; Jin, J.; Tao, W. Y Studies on active substance of anticancer effect in Polygonum cuspidatum. J. Chin. Med. Mater., 2006, 29, 689-691.
36. Wang, X. F.; Wang, Y. M.; Liu, F.; Wei, K. L. The inhibitory effect of decomposed Chinese traditional medicine Chaihu on Coxsackie B virus (CVB3m) replication and its influence on cell activity. Chin. J. Exp. Clin. Virol, 2001, 15, 281-282.
37. Gottschalk, I.; Lagerquist, C; Zuo, S. S.; Lundqvist, A.; Lundahl, P. Immobilized-biomembrane affinity chromatography for binding studies of membrane proteins. J. Chromatogr. B, 2002, 768, 31-40.
38. Moaddel, R.; Wainer, I. W. Development of immobilized membrane-based affinity columns for use in the online characterization of membrane bound proteins and for targeted affinity isolations. Analytica Chimica Acta, 2006, 564, 97-105.
39. Yue, X. F.; Zhang, Y. N.; Zhang, Z. Q.; Tian, Z. J.; Yang, J. X.; Li, F. R. Study on the interactions between Ligusticum chuanxiong extract and cardiac muscle membrane receptors by CMSP chromatography. China J. Chin. Mater. Med., 2005, 30, 129-132.
40. Lin, R.; Yang, G. D.; Wang, W. R.; Liu, J. T.; He, L. C.; Peng, N.; Han, C. J.; Liu, Y. Screening the active components of Salvia miltiorrhiza for atherosclerosis with chromatography of CD40 highly expressed cell membrane. Chin. Herbal Med., 2006, 29, 1315-1318.
41. Li, S. L.; Li, P.; Sheng, L. H.; Li, R. Y.; Qi, L. W.; Zhang, L. Y. Live cell extraction and HPLC-MS analysis for predicting bioactive components of traditional Chinese medicines. J. Pharm. Biomed. Anal., 2006, 41, 576-581.
42. Zhang, X.; Qi, L. W.; Li, P.; Yu, Q. T.; Li, Y. R.; Ren, M. T. Cell extraction coupled with high performance liquid chromatography electrospray ionization time-of-flight mass spectrometry analysis for screening and identification of potential bioactive components in Radix Astragali. Chin. J. Anal. Chem., 2008, 36, 745-749.
43. Zhao, H. R.; Yang, G. D.; He, L. C. Screening the effective component of Angelica sinensis by cell membrance chromatography. Chin. Pharm. J. 2000, 35, 13-15.
44. Zhang, H. L.; Yang, G. D.; He, L. C.; Yang, Y. J. Studies on screening the effective components of Cladonia alpestris and its correlation with pharmacological effects. Chin. Pharm. J., 2003, 38, 92-94.
45. Zhang, Y. J.; He, L. C. Screening active components inhibiting HeLa cell proliferation in Libanotis buethorimenisis by using the model of cell membrane chromatography. Chin. J. Pharm., 2005, 40, 463-465.
46. Zhao, X. J. Dang, G. C.; Yang, G. D.; He, L. C. Analysis and comparison of the effective component in the roots and leaves of Herba Eplmedii. Chin. J. Anal. Chem., 2002, 30, 195-197.
47. Gao, K.; He, L. C.; Yang, G. D. Screening the effective component of Leontice robustumby cell membrane chromatography. Chin. Pharm. J., 2003, 38, 14-16.
48. Li, C. Q.; He, L. C. Establishment of the model of white blood cell membrane chromatography and screening of antagonizing TLR4 receptor component from Atractylodes macrocephala Koidz. Sci. China: Ser. C Life Sci., 2005, 35, 545-550.
49. González, J. E.; Oades, K.; Leychkis, Y.; Harootunian, A.; Paul A. Negulescu Cell-based assays and instrumentation for screening ionchannel targets. Drug Disc. Today, 1999, 4, 431-439.
50. Guo, X. G.; Chen, J. Z.; Zhang, X.; Xia, Q. Effect of puerarin on L-type calcium channel in isolated rat ventricular myocytes. China J. Chin. Mater. Med., 2004, 29, 248-251.
51. Zhang, G. Q.; Hao, X. M.; Chen, S. Z.; Zhou, P. A.; Cheng, H. P.; Wu, C. H. Blockade of paeoniflorin on L-type calcium channel in isolated rat ventricular myocytes. Chin. Pharm. Bull., 2003, 19, 863-866.
52. Zhang, X. G.; Wang, J. N.; Li, J. J.; Liu, Z. W.; Huang, C. X. Effects of Ginkgo biloba extract on action potential and L-type calcium channel in guinea pig's ventricular myocytes. Chin. J. Clin. Pharmacol. Ther., 2004, 9, 345-349.
53. Chen, M. K.; Luo, H. S.; Yu, B. P. Effects of berberine on potassium current of guinea pig colonic smooth muscle cells. Chin. Pharm. Bull., 2004, 20, 632-635.
54. Li, N.; Huo, Y. P.; Ma, K. J.; Sun, Q.; Pu, J. L. The effect of Shensongyangxin capsule on potassium channel currents in isolated ventricular myocytes. Chin. J. Diff. Comp. Cases 2007, 6, 133-137.
55. Li, S. Y.; Ouyang, S. Emodin blocks voltage dependent potassium channels in rat proximal colon smoothmuscle cells. Acta Pharmaceutica Sinica, 2005, 40, 804-809.
56. Chen, Z. N. Receptor technology and drug development. Chin. J. Pharm., 1994, 49, 362-365.
57. Navlor, L. H. Reporter gene technology: the future looks bright. Biochem. Pharmacol., 1999, 58, 749-757.
58. Tavaré, J. M.; Fletcher, L. M.; G I Welsh, G. I. Using green fluorescent protein to study intracellular signaling. J. Endocrinol., 2001, 170, 297-306.
59. New, D. C. DM Miller-Martini, D. M.; Wong, Y. H. Reporter gene assays and their applications to bioassays of natural products. Phytother. Res., 2003, 17, 439-448.
60. Zheng, X. K.; Lv, P. F.; Wang, L. Q.; Feng, W. S.; Wang, J. F.; Niu, J. Z. Experimental study of estrogenic activities of five kinds of Chinese herbal medicines. China J. Chin. Mater. Med., 2006, 31, 1254-1257.
61. Zhu, P. T.; Bu, P.; Chen, X. Y.; Wu, Y. J.; Chen, C. B.; Li, X. M. Use W303-1A/hER-ERE-Lac Z to determine estrogenic compounds in traditional Chinese material medic. China J. Chin. Materia Med., 2007, 32, 2636-2639.
62. Li, Y.; Piao, P.; Chen, X. Y; Wu, YJ.; Chen, C. B.; Li, X. M. Inducement of ginsenoside Rg1on expression of glucocorticoid receptor report gene in HL-7702 cells. Chin. Trad. Herb. Drugs, 2006, 37, 1823-1826.
63. Tang, J. H.; Gao, X. P; Zhang, YZ. Construction of LDLR/Luc reporter system and screening of cholesterol-lowering drug from traditional Chinese medicine. Nat. Prod. Res. Dev., 2005, 17, 316-319.
64. Zhang, D. M.; Qin, Y.; Yang, J.; Yu, H.; Niu, F. L.; Zhu, L. Q.; Wang, S. R.; Jiang, L. D.; Zhou, C. H. Effects of Tetramethylpyrazine on the transcriptional activity of α1 Type I collagen promoter Induced by Angiotensin II. Chin. J. Inf. TCM 2005, 12, 21-22.
65. Chen, W. Z.; Zeng, X.; Xie, W. F.; Zhang, X. Effect of matrine on cell proliferation and regulation of telomerase activity in hepatoma cells in vitro. J. Oncol, 2002, 8, 168-170.
66. Bertucci, C; Bartolini, M.; R. Gotti, R.; Andrisano, V. Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis. J. Chromatogr. B, 2003, 797, 111-129.
67. Kong, L.; Zou, H. F.; Wang, H. L.; Ni, J. Y.; Zhang, YK. Analysis of biologically active compounds in Chinese medicines by molecular biochromatography with human serum album in (HSA) stationary phase. Chem. J. Chin. Univ., 2000, 21, 36-40.
68. Lennon, G. G. High-throughput gene expression analysis for drug discovery. Drug Discov. Today, 2000, 5, 59-66.
69. Kim, H. L. Comparison of oligonucleotide-microarray and serial analysis of gene expression (SAGE) in transcript profiling analysis of megakaryocytes derived from CD34+ cells. Exp. Mol. Med. 2003, 35, 460-466.
70. Roda, A.; Pasini, P.; Mirasoli, M.; Michelini, E; Guardigli M. Biotechnological applications of bioluminescence and chemiluminescence. Trends Biotechnol, 2004, 22, 295-303.
71. Wang, Y. J.; Shi, Q.; Li, J. S.; Jia, L. X.; Zhou, C. J.; Liu, M. The Effects of Yiqi study on the gene expression profile of cervical intervertebral disc requlated by Yiqi Huayu Fang in rats. Chin. J. Basic Med. Tradit. Chin. Med., 2003, 9, 32-37.
72. Leng, S. L.; Dong, X. X. Study on gene expression detection during neural cell differentiation of rat mesenchymal stem cells introduced by Chinese medicine filtrated by gene chip. Ner. Dis. Ment. Health, 2005, 5, 253-256.
73. Wu, W. K.; Tan, H. M.; Luo, H. C.; Zhao, M. Q.; Liang, T. W. Study on differentially expressed genes in ischemic myocardium and the effect of Sini decoction on them by DNA microarray. Chin. J. Pathophysiol, 2003, 19, 207-210.
74. Li, T. J.; Qiu, Y; Rui, Y. C.; Li, T. Z.; Zhang, W. D. DNA microarray analysis of protective mechanism of Buyang Huanwu decoction on focal cerebral ischemia/reperfusion in rats. China J. Chin. Mater. Med., 2004, 29, 559-563.
75. Bao, Y. X.; Huang, Z. G.; Li, J.; Lin, W. J. Gene microarray technique for observing the immunomodulatory effects of nasopharyngeal carcinoma patients after taking Yunzhi-Danshen capsules. Immunol. J., 2006, 22, 523-526.
76. Wang, J. J.; Qian, X. Y.; Li, X.; Yang, H. H.; Liang, Q. L.; Wang, Y. M.; Luo, G. A. Screening and cluster of differentially expressed MSCs genes induced by Shuanglong prescription. World Sci. Technol Mod. Trad. Chin. Med. Mater. Medic, 2007, 9, 39-42.
77. Jiang, D. Y; Bai, Y. B.; Yao, L.; Chen, Y. K.; Wang, B.; Liu, C. G.; Fetherston, PR.; Liu, Z.; Li, X. Y. Effects of Tang Xin Kang on Alox-12mRNA gene expression in diabetes induced cardiomyopathy. World Sci. Technol Mod. Trad. Chin. Med. Mater. Med., 2008, 10, 23-26.
78. Yu, R. J.; Pu, H. L.; Zhou, T. H.; Li, Z. Y.; Lin, J. Effect of Liuwei Dihuang Wan on the expression of genes in aged rats by cDNA microarray. Chin. J. Pathophysiol, 2004, 20, 260-265.
79. Anderson, N. I.; Anderson, N. G. Proteome and Proteomics: new technologies, new concepts, and new words. Electrophoresis, 1998, 19, 1853-1861.
80. Blackstock, W. P.; Weir, M. P. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol., 1999, 17, 121-127.
81. Banks, R. E.; Dunn, M. J.; Hochstrasser, D. F.; Jean-Charles Sanchez, J. C.; Blackstock, W.; Pappin, D. J.; Selby, P. G. Proteomics: new perspectives, new biomedical opportunities. Lancet, 2000, 356, 1749-1756.
82. Yan, L., Lao, Y. M., Jiang, J. G. Action mechanisms of Chinese herbal compound at the molecular level. Lett. Drug Design Dis., 2009, 6, 397-402.
83. Ma, Z. C.; Gao, Y.; Tan, H. L.; Wang, S. Q. The Effects of Si-Wu-Tang on serum protein of blood deficient mice induced by radiation. China J. Chin. Mater. Med., 2003, 28, 1050-1053.
84. Yan, D. M.; Li, H.; Liu, Q. J.; Liu, Y. P.; Yang, Y. The Effect of Si Jun. Zi Decoction on neuronal expression of mouse proteome. Pharmacol. Clin. Chin. Mater., 2008, 24, 10-12.
85. Liu, Y.; Liu, P.; Wang, L. The effect of Fuzheng Huayu Deoction on the hepatic proteome during the formation and resolution of rat liver fibrosis. Chin. J. Hepatol., 2006, 14, 422-425.
86. Zhang, C.; Wang, P. X.; Zhou, L.; Dong, Y. Effect of removing stasis medicinal herbs on proliferation and proteomics of THP-1 cell line induced by endotoxin. Chin. J. Immunol., 2006, 22, 662-670.
87. Cao, Y. Y. Wang, M.; Huang, K. S.; Yang, Q.; Ding, M. Proteomic analysis of differentially expressed proteins in human hepatoma SMMC-7721cells induced by Fufang Banmao capsule serum. China J. Chin. Mater. Med., 2007, 32, 831-834.
88. Zou, H. F.; Wang, H. L. Separation, Differentiation and screening of active constituents in traditional Chinese drugs by biochromatography. World Sci. Technol. Mod. Trad. Chin. Med., 2000, 2, 9-13.
89. Li, W. F.; Jiang, J. G.; Chen, J. Chinese medicine and its modernization demands. Arch. Med. Res., 2008, 39, 246-251.
90. Wang, N.; Duan, J. A.; Zhu, Q.; Ding, A. W.; Li, Q. L.; Peng, D. Y. Cyto-membrane biochromatography and its application in TCM study. World Sci. Technol. Mod. Trad. Chin. Med., 2008, 10, 82-85.
91. Fang, Y. L.; Zhang, Y.; Xiao, X. H.; Du, J.; Zhang, J. Advances in studies on application of cell membrane chromatography in screening bioactive components of Chinese materia medica. Chin. Trad. Herb. Drugs., 2008, 39, s3-5.
92. Chen, T.; Zhou, J. Y.; Xu, B. Application progress of cell membrane chromatography in pharmacology mycolog. Chin. Arch. Tradit. Chin. Med., 2007, 25, 983-985.
93. Schena, M.; Heller, R. A.; Thenault, P. T.; Konrad, K.; Lachenmeier, E.; Davis, R. W. Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol., 1998, 16, 301-306.
94. Peng, J.; Gygi, S. P. Proteomics: the move to mixtures. J. Mass Spectrom., 2001, 36, 1083-1091.